Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ReciBioPharm
Watertown, Massachusetts, United Statesrecipharm.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
ReciBioPharm provides end-to-end biologics development and manufacturing services for advanced therapies including mRNA, plasmid DNA, viral vectors/live viruses, lipid nanoparticles, microbiome therapeutics. It enables pre-clinical through commercial supply for global biotech/pharma clients developing ATMPs. No proprietary clinical results as it does not have its own drug pipeline.
- Modalities
- mRNA-based drugsPlasmid DNA production (Nucleic acid-based therapy)Viral vector and live virus therapyMicrobial therapy (Live-microbial biopharmaceutical products, microbiome live biotherapeutics)Lipid nanoparticle delivery therapyCell and viral banking servicesATMP fill and finish
- Industry
- Contract Manufacturing Organization
02
Partnerships
Not specifically disclosed; works with multiple global biotech/pharma companies as contract partners.
Beyond the preview
Go deeper on ReciBioPharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ReciBioPharm.